Dr. Zabriskie is a Co-founder and Senior Partner at PureTech Ventures. He is past Chairman of the Board, CEO and President of NEN Life Science Products, Inc., a leading supplier of kits for labeling and detection of DNA. At NEN Dr. Zabriskie led the successful turnaround and sale of the company in a transaction that generated a 20x return for investors. Prior to joining NEN, Dr. Zabriskie was President and CEO of Pharmacia and Upjohn, Inc., a Fortune 500 pharmaceutical company formed by the merger of Pharmacia AB of Sweden and the Upjohn Company of Kalamazoo, Michigan.
As Chairman of the Board and CEO of the Upjohn Company, Dr. Zabriskie led the Upjohn project, which resulted in the $12 billion merger of equals. Prior to joining Upjohn in 1994, Dr. Zabriskie was Executive Vice President of Merck and Co., Inc. Dr. Zabriskie was a member of the US Healthcare Leadership Council, and has served on a number of boards for healthcare and academic institutions.
He currently serves on the boards of PureTech Ventures, the Kellogg Co., Array BioPharma, and ARCA Discovery. Dr. Zabriskie is a native of Aurora, NY and received his AB in chemistry from Dartmouth College and his PhD in organic chemistry from the University of Rochester.